Quantifying Glans Width Changes in Response to Preoperative Androgen Stimulation in Patients Undergoing Hypospadias Repair

Purpose:Testosterone (T) administration prior to hypospadias surgery to increase glans size remains controversial. Understanding T's effect on glans width (GW) is essential to understanding its potential impact on surgical outcomes. We hypothesized that preoperative T in prepubertal boys signif...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of urology Vol. 207; no. 6; pp. 1314 - 1321
Main Authors Mittal, Sameer, Eftekharzadeh, Sahar, Christianson, Sarah S., Hyacinthe, Nathan, Tan, Connie, Weiss, Dana A., Van Batavia, Jason, Zderic, Steve A., Shukla, Aseem R., Kolon, Thomas F., Srinivasan, Arun K., Canning, Douglas A., Zaontz, Mark R., Long, Christopher J.
Format Journal Article
LanguageEnglish
Published Philadelphia, PA Wolters Kluwer 01.06.2022
Subjects
Online AccessGet full text
ISSN0022-5347
1527-3792
1527-3792
DOI10.1097/JU.0000000000002481

Cover

More Information
Summary:Purpose:Testosterone (T) administration prior to hypospadias surgery to increase glans size remains controversial. Understanding T's effect on glans width (GW) is essential to understanding its potential impact on surgical outcomes. We hypothesized that preoperative T in prepubertal boys significantly increases GW at the time of hypospadias surgery.Materials and Methods:Our single institutional database was queried to identify patients who underwent hypospadias surgery from 2016 to 2020, in which data for T administration and GW were available. Descriptive, nonparametric and categorical statistics were performed as indicated.Results:A total of 579 patients were eligible for analysis. Median age at surgery was 0.9 years (IQR 0.6-1.6). A total of 247/579 patients (42.7%) received T. The median GW at surgery was 15 mm (IQR 13-17). When comparing patients who had T administered to those who did not, we found a significant difference in GW at surgery (16 mm vs 14 mm, p <0.001). The median change in GW from the office to surgery was 4 mm for those receiving T vs 0 mm for those not receiving T (p <0.001). We identified a greater change in GW from preoperative to intraoperative measurements in patients who received 2 doses of T vs 1 dose (4 mm vs 2 mm, p <0.001). A histogram plot revealed the distribution of GW change at surgery.Conclusions:In our prospectively collected cohort of patients undergoing hypospadias surgery, we were able to quantitate the change in GW from preoperative T. Two doses of T resulted in a significant increase in GW vs 1 dose.
Bibliography:Correspondence: Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Children's Hospital of Pennsylvania, 3401 Civic Center Blvd., Philadelphia, Pennsylvania 19104 telephone: 215-590-1477; FAX: 215-590-3985; longc3@chop.eduSupport: National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases K08 grant (Jason Van Batavia), Children's Hospital of Philadelphia Division of Urology endowment (Douglas A. Canning).Conflict of Interest: Jason Van Batavia: Expert witness for malpractice case (past), Steve A. Zderic: Urogenie, Arun K. Srinivasan: Intuitive Surgical (past).Ethics Statement: Study received Institutional Review Board approval (IRB No. 12-009259).*Co-first authors.See Editorial on page 1180.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-5347
1527-3792
1527-3792
DOI:10.1097/JU.0000000000002481